Gain insight into research trends and influential papers with Research Intelligence.
doi.org/10.1016/j.ygyno.2020.06.025

Avelumab in combination with and/or following chemotherapy vs chemotherapy alone in patients with previously untreated epithelial ovarian cancer: Results from the phase 3 javelin ovarian 100 trial

..., Myong Cheol Lim
33
Gynecologic Oncology4.70
Volume: 159, Pages: 13 - 14
Published: Oct 1, 2020
Abstract
Objective: This randomized, open-label, phase 3 trial (JAVELIN Ovarian 100; NCT02718417) evaluated avelumab in combination with and/or following chemotherapy versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer...
Paper Fields
Paper Details
Title
Avelumab in combination with and/or following chemotherapy vs chemotherapy alone in patients with previously untreated epithelial ovarian cancer: Results from the phase 3 javelin ovarian 100 trial
DOI
doi.org/10.1016/j.ygyno.2020.06.025
Published Date
Oct 1, 2020
Journal
Gynecologic Oncology
Volume
159
Pages
13 - 14
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.